Table TDI-25 part (iii). Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2003: the combination of cannabis, opiates, cocaine or other stimulants as primary drug type with a secondary drug. All clients with cocaine as primary drug: numbers reporting the stated drug as secondary

Country

Opiates

Cocaine

Other stimulants

Hypnotics, sedatives

Hallucinogens

Volatile inhalants

Cannabis

Alcohol

Others

Total

Czech Republic

1

0

1

 

 

 

2

 

 

4

Denmark

 

 

 

 

 

1

46

51

10

108

Germany

 

 

 

 

 

6

909

618

84

1617

Greece

11

1

8

4

7

0

15

2

2

50

Cyprus

4

 

2

 

 

 

 

 

 

6

Luxembourg

 

 

 

1

 

 

8

3

 

12

Hungary

 

 

4

 

 

 

 

2

 

6

Malta

 

 

 

 

 

 

21

2

3

26

Netherlands

540

23

232

59

2

1

741

933

39

2570

Slovenia

5

 

2

 

 

 

1

1

2

11

Slovakia

2

 

4

 

 

 

5

2

 

13

Finland

 

 

 

 

 

 

2

 

 

2

Bulgaria

 

 

 

 

 

 

1

 

 

1

Total

563

24

253

64

9

8

1751

1614

140

4426

Notes:

Data on secondary drug use are only collected among all treatment clients and not separately for new treatment clients

Opiates include: heroin, methadone, other opiates; Cocaine includes: Cocaine CIH, crack cocaine; Stimulants include: amphetamines, MDMA and derivates, other stimulants: Cannabis can include herb or resin. For each client up to four secondary drugs can be reported

A number of the clients report using the same drug both as primary and secondary drug, particulary for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories. The greater part of clients using cannabis both as primary and secondary drug comes from Germany

Source:

2004 Reitox national reports – see [Table TDI-19]

Data filter | tditab25c-en.xml